New Pharma CEE, UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2020 |
|---|
| 119,400 |
| 38,516 |
| -9,080 |
| -9,080 |
| -2,929 |
| 100.00 |
| -7.60 |
| 1,491,118 |
| 2,166,650 |
| 319,925 |
| 3,337,608 |
| 2021 |
|---|
| 176,029 |
| 40,747 |
| 162,235 |
| 161,894 |
| 37,475 |
| 100.00 |
| 91.97 |
| 1,503,012 |
| 2,492,740 |
| 319,783 |
| 3,678,562 |
| 2022 |
|---|
| 243,750 |
| 121,269 |
| 99,165 |
| 98,182 |
| 48,847 |
| 100.00 |
| 40.28 |
| 1,276,194 |
| 2,493,912 |
| 286,128 |
| 3,485,816 |
Register and
explore Okredo data| 2022 |
|---|
| 243,750 |
| 121,269 |
| 99,165 |
| 98,182 |
| 48,847 |
| 100.00 |
| 40.28 |
| 1,276,194 |
| 2,493,912 |
| 286,128 |
| 3,485,816 |
Register and
explore Okredo data2022
Turnover (€)
243,750 €
38 % *
Sales per employee (€)
121,269 €198 % *
Profit before tax (€)
99,165 €
-39 % *
Net Profit (€)
98,182 €-39 % *
Profit per employee (€)
48,847 €30 % *
Total profitability (%)
100.00 %
0.00 % *
Net profitability (%)
40.28 %-56.20 % *
Equity (€)
1,276,194 €-15 % *
Amounts Payable And Liabilities (€)
2,493,912 €
0 % *
Non-current Assets (€)
286,128 €
-11 % *
CurrentAssets (€)
3,485,816 €-5 % *